The taxanes: toxicity and quality of life considerations in advanced ovarian cancer

The taxanes paclitaxel and docetaxel show good activity in the management of advanced ovarian cancer when used in conjunction with platinum agents. Accumulating evidence from clinical studies, particularly the latest results from the phase III comparative SCOTROC study, indicates that the two drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Guastalla III, J P, Diéras, V
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750618/
https://www.ncbi.nlm.nih.gov/pubmed/14661042
http://dx.doi.org/10.1038/sj.bjc.6601496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750618/
https://www.ncbi.nlm.nih.gov/pubmed/14661042
http://dx.doi.org/10.1038/sj.bjc.6601496

Ejemplares similares